The LATAM AIM (Latin American chapter of the American Initiative in Mast Cell Diseases) invites the global mast cell diseases community to support its international patient survey.
It aims to improve understanding of mast cell activation disorders, including mastocytosis and mast cell activation syndrome (MCAS), as well as hereditary alpha-tryptasemia (HαT).
The survey aims to gather patient insights on symptoms, triggers, comorbidities, treatments, laboratory markers and quality of life.
Participation in this survey is anonymous and will characterise patient experiences worldwide, helping improve understanding of disease burden and treatment response.